Literature DB >> 32327148

Structural and cellular biology of adeno-associated virus attachment and entry.

James Zengel1, Jan E Carette2.   

Abstract

Adeno-associated virus (AAV) is a nonenveloped, ssDNA virus in the parvovirus family, which has become one of the leading candidate vectors for human gene therapy. AAV has been studied extensively to identify host cellular factors involved in infection, as well as to identify capsid variants that confer clinically favorable transduction profiles ex vivo and in vivo. Recent advances in technology have allowed for direct genetic approaches to be used to more comprehensively characterize host factors required for AAV infection and allowed for identification of a critical multi-serotype receptor, adeno-associated virus receptor (AAVR). In this chapter, we will discuss the interactions of AAV with its glycan and proteinaceous receptors and describe the host and viral components involved in AAV entry, which requires cellular attachment, endocytosis, trafficking to the trans-Golgi network and nuclear import. AAV serves as a paradigm for entry of nonenveloped viruses. Furthermore, we will discuss the potential of utilizing our increased understanding of virus-host interactions during AAV entry to develop better AAV-based therapeutics, with a focus on host factors and capsid interactions involved in in vivo tropism.
© 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AAVR; Adeno-associated virus; Adeno-associated virus receptor; Attachment; Gene therapy; KIAA0319L; Receptor; Structure; Trafficking; Virus-host interaction

Mesh:

Substances:

Year:  2020        PMID: 32327148     DOI: 10.1016/bs.aivir.2020.01.002

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN: 0065-3527            Impact factor:   9.937


  7 in total

Review 1.  Intracellular trafficking of adeno-associated virus (AAV) vectors: challenges and future directions.

Authors:  Jalish M Riyad; Thomas Weber
Journal:  Gene Ther       Date:  2021-03-03       Impact factor: 4.184

2.  Molecular Signature of Astrocytes for Gene Delivery by the Synthetic Adeno-Associated Viral Vector rAAV9P1.

Authors:  Amelie Bauer; Matteo Puglisi; Dennis Nagl; Joel A Schick; Thomas Werner; Andreas Klingl; Jihad El Andari; Veit Hornung; Horst Kessler; Magdalena Götz; Dirk Grimm; Ruth Brack-Werner
Journal:  Adv Sci (Weinh)       Date:  2022-04-10       Impact factor: 17.521

3.  Hydroxylation of N-acetylneuraminic Acid Influences the in vivo Tropism of N-linked Sialic Acid-Binding Adeno-Associated Viruses AAV1, AAV5, and AAV6.

Authors:  Estrella Lopez-Gordo; Alejandro Orlowski; Arthur Wang; Alan Weinberg; Susmita Sahoo; Thomas Weber
Journal:  Front Med (Lausanne)       Date:  2021-12-21

Review 4.  Adeno-Associated Viruses (AAV) and Host Immunity - A Race Between the Hare and the Hedgehog.

Authors:  Kleopatra Rapti; Dirk Grimm
Journal:  Front Immunol       Date:  2021-10-29       Impact factor: 7.561

Review 5.  AAV-mediated gene therapy: Advancing cardiovascular disease treatment.

Authors:  Huili Zhang; Qi Zhan; Biao Huang; Yigang Wang; Xiaoyan Wang
Journal:  Front Cardiovasc Med       Date:  2022-08-19

Review 6.  Next Step in Gene Delivery: Modern Approaches and Further Perspectives of AAV Tropism Modification.

Authors:  Maxim A Korneyenkov; Andrey A Zamyatnin
Journal:  Pharmaceutics       Date:  2021-05-19       Impact factor: 6.321

Review 7.  Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry.

Authors:  Edward E Large; Mark A Silveria; Grant M Zane; Onellah Weerakoon; Michael S Chapman
Journal:  Viruses       Date:  2021-07-10       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.